Evidence map›Paper›PMID 28403150›Full record

ArticlePloS one2017

PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro.

Dalia Martinez-Marin, Courtney Jarvis, Thomas Nelius, Werner de Riese, Olga V Volpert, Stéphanie Filleur

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Natural products and other inhibitors of FEuropean journal of medicinal chemistry · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dalia Martinez-MarinDepartment of Urology, Texas Tech University-Health Sciences Center, Lubbock, Texas, United States of America.
Courtney JarvisDepartment of Urology, Texas Tech University-Health Sciences Center, Lubbock, Texas, United States of America.
Thomas NeliusDepartment of Urology, Texas Tech University-Health Sciences Center, Lubbock, Texas, United States of America.
Werner de RieseDepartment of Urology, Texas Tech University-Health Sciences Center, Lubbock, Texas, United States of America.
Olga V VolpertDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Stéphanie FilleurDepartment of Urology, Texas Tech University-Health Sciences Center, Lubbock, Texas, United States of America.ORCID http://orcid.org/0000-0002-3420-5536
Texas Tech University · USNorthwestern University · US

Funding

Modulation of Pigment Epithelium-Derived Factor's activities as potential therapeR15CA161634 · NCI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI FILLEUR, STEPHANIE, NELIUS, THOMAS · 2012 to 2014
$545k
NCI NIH HHS R15 CA161634
6 · The paper itself

Abstract

backgroundAlthough inflammation and prostate cancer (PCa) have been linked, the molecular interactions between macrophages and PCa cells are poorly explored. Pigment Epithelium-Derived Factor (PEDF) is an anti-angiogenic and anti-tumor factor. We previously showed that PEDF induces macrophages recruitment in vitro, correlates with macrophages density in human prostate, and stimulates macrophages polarization towards the classically activated pathway. Here, we demonstrate that PEDF modulates the interaction between macrophages and PCa cells through a bidirectional signalling leading to tumor cell apoptosis and phagocytosis.

methodsRAW 264.7 and THP-1 cells, and BMDMs were grown in vitro as mono- or co-cultures with PC3 or CL1 tumor cells. The effects of PEDF and its derived P18 peptide were measured on macrophages differentiation, migration, and superoxide production, and tumor cell apoptosis and phagocytosis. PEDF receptors (ATP5B, PNPLA2, and LRP6) and CD47 mRNA and protein expression were quantified in macrophages and tumor cells by quantitative RT-PCR, western blot, immunofluorescence and flow cytometry.

resultsWe found that PEDF induced the migration of macrophages towards tumor 3D spheroids and 2D cultures. In co-culture, PEDF increased PCa cells phagocytosis through an indirect apoptosis-dependent mechanism. Moreover, PEDF stimulated the production of superoxide by macrophages. Conditioned media from macrophages exposed to PEDF induced tumor cells apoptosis in contrast to control conditioned media suggesting that ROS may be involved in tumor cells apoptosis. ATP5B and PNPLA2 PEDF receptors on macrophages and CD47 on tumor cells were respectively up- and down-regulated by PEDF. As PEDF, blocking CD47 induced phagocytosis. Inhibiting ATP5B reduced phagocytosis. Inversely, PNPLA2 inhibition blocks differentiation but maintains phagocytosis. CD47-induced phagocytosis was partially reverted by ATP5B inhibition suggesting a complementary action. Similar effects were observed with P18 PEDF-derived peptide.

conclusionsThese data established that modulating the molecular interactions between macrophages and PCa cells using PEDF may be a promising strategy for PCa treatment.

Indexed as

AcyltransferasesAnimalsAntineoplastic AgentsCD47 AntigenCell Line, TumorCell MovementCoculture TechniquesDrug Screening Assays, AntitumorEye ProteinsHumansLipaseMacrophagesMaleMiceMitochondrial Proton-Translocating ATPasesNerve Growth FactorsAcyltransferasesAntineoplastic AgentsatglistatinATP5b protein, mouseCD47 AntigenEye ProteinsLipaseMitochondrial Proton-Translocating ATPasesNerve Growth FactorsPhenylurea CompoundsPigment Epithelium-Derived FactorPNPLA2 protein, mouseSerpinsSuperoxides

Identifiers

PMID28403150
PMCPMC5389654
OpenAlexW2605708780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.